Employee-Paid

Dr. Tim Church predicted recently that GLP-1 agonists, GLP-1 /GIP agonists and similar prescription drugs will soon be as much a part of the medication infrastructure as statins or thyroid pills.

Witnesses at a Senate hearing on health care costs attacked insurer dealmaking and data access restrictions.

CVS Health, the parent of Aetna, likes its employer health plan business but is taking a tough approach to pricing, a company executive said Friday.

Most employees said health plans should cover GLP-1 medications, with 64% saying they should and 12% saying they should not.

Top executives from benefits providers and benefits brokers are telling investors that, for now, at least, the U.S. labor market still looks pretty good.

Committee members hope the Employee Benefits Security Administration will do more to enforce mental health parity laws.